inking movement execution and perception in Autism Spectrum Disorder
Completed
- Conditions
- Autism Spectrum DisoderAsperger syndrome10010118
- Registration Number
- NL-OMON46081
- Lead Sponsor
- Radboud Universiteit Nijmegen
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 70
Inclusion Criteria
Age 18-40, IQ > 85, right-handed, normal or corrected-to-normal vision.
Exclusion Criteria
History of (neuro-)psychiatric disorders, brain surgery or brain trauma; use of anti-psychotic medication. For neuroimaging experiment: metal objects in the body that cannot be removed, such as pacemakers or metal prostheses, claustrophobia or panic in the scanner.
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie atypical movement and perception in Autism Spectrum Disorder as studied in NL-OMON46081?
Are there specific biomarkers associated with motor execution deficits in Asperger syndrome patients enrolled in NL-OMON46081?
How does the observational design of NL-OMON46081 contribute to understanding sensory-motor integration in 10010118 disease subtype?
What are the potential implications of NL-OMON46081 findings for developing non-invasive therapeutic strategies targeting ASD motor phenotypes?
How do movement perception abnormalities in Autism Spectrum Disorder compare to other neurodevelopmental disorders in observational studies?